BRPI0823082A2 - Uso derivados de sesquiterpeno - Google Patents

Uso derivados de sesquiterpeno

Info

Publication number
BRPI0823082A2
BRPI0823082A2 BRPI0823082-0A BRPI0823082A BRPI0823082A2 BR PI0823082 A2 BRPI0823082 A2 BR PI0823082A2 BR PI0823082 A BRPI0823082 A BR PI0823082A BR PI0823082 A2 BRPI0823082 A2 BR PI0823082A2
Authority
BR
Brazil
Prior art keywords
sesquiterpene derivatives
sesquiterpene
derivatives
use sesquiterpene
Prior art date
Application number
BRPI0823082-0A
Other languages
English (en)
Inventor
Tae-Sun Park
Ha-Won Kim
Original Assignee
Kwang Dong Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kwang Dong Pharm Co Ltd filed Critical Kwang Dong Pharm Co Ltd
Publication of BRPI0823082A2 publication Critical patent/BRPI0823082A2/pt
Publication of BRPI0823082B1 publication Critical patent/BRPI0823082B1/pt
Publication of BRPI0823082B8 publication Critical patent/BRPI0823082B8/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Food Science & Technology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
BRPI0823082A 2008-09-11 2008-10-20 composições de derivados de sesquiterpeno para prevenir ou tratar hiperlipidemia, fígado gordo, diabetes ou obesidade BRPI0823082B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020080089971A KR100905419B1 (ko) 2008-09-11 2008-09-11 세스퀴테르펜 유도체의 용도
KR10-2008-0089971 2008-09-11
PCT/KR2008/006198 WO2010030054A2 (en) 2008-09-11 2008-10-20 Uses of sesquiterpene derivatives

Publications (3)

Publication Number Publication Date
BRPI0823082A2 true BRPI0823082A2 (pt) 2015-06-16
BRPI0823082B1 BRPI0823082B1 (pt) 2019-02-26
BRPI0823082B8 BRPI0823082B8 (pt) 2021-05-25

Family

ID=41337139

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0823082A BRPI0823082B8 (pt) 2008-09-11 2008-10-20 composições de derivados de sesquiterpeno para prevenir ou tratar hiperlipidemia, fígado gordo, diabetes ou obesidade

Country Status (9)

Country Link
US (1) US8481592B2 (pt)
EP (1) EP2331089B1 (pt)
JP (1) JP5435375B2 (pt)
KR (1) KR100905419B1 (pt)
CN (1) CN102143741B (pt)
BR (1) BRPI0823082B8 (pt)
ES (1) ES2560533T3 (pt)
MX (1) MX2011001594A (pt)
WO (1) WO2010030054A2 (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2345646A1 (en) * 2010-01-14 2011-07-20 InterMed Discovery GmbH Use of tricyclic sesquiterpene lactones in the treatment of obesity and related diseases and non-therapeutic treatable conditions
KR101138565B1 (ko) * 2010-03-25 2012-05-10 동아제약주식회사 비만 또는 지질 관련 대사성 질환의 치료 또는 예방용 조성물
WO2013186766A1 (en) * 2012-06-11 2013-12-19 Regenera Pharma Ltd. Extracts and therapeutic uses thereof
CN103626636B (zh) * 2013-11-06 2015-04-08 中国科学院南海海洋研究所 一种链霉倍半萜三醇及其制备方法和应用
US20160092661A1 (en) * 2014-09-26 2016-03-31 The Procter & Gamble Company Method of making perfumed goods
CN108369223B (zh) * 2015-12-30 2021-07-06 雀巢产品有限公司 用于测定去脂体重的方法
CN119033604A (zh) 2016-03-24 2024-11-29 宝洁公司 包含恶臭减少组合物的毛发护理组合物
KR101674622B1 (ko) * 2016-07-07 2016-11-09 국민대학교산학협력단 세스퀴테르펜 유도체의 신규한 용도
KR102061933B1 (ko) 2017-06-23 2020-01-02 연세대학교 산학협력단 세스퀴테르펜 유도체를 유효성분으로 함유하는 근력강화, 근육증강, 근육분화, 근육재생 또는 근감소증 억제효과를 갖는 조성물
WO2019074990A1 (en) 2017-10-10 2019-04-18 The Procter & Gamble Company COMPACT SHAMPOO COMPOSITION
US10792384B2 (en) 2017-12-15 2020-10-06 The Procter & Gamble Company Rolled fibrous structures comprising encapsulated malodor reduction compositions
KR20210022504A (ko) * 2019-08-20 2021-03-03 엠에프씨 주식회사 신규 세스퀴테르펜 유도체(1) 및 이의 용도
CN114746153A (zh) 2019-12-06 2022-07-12 宝洁公司 具有增强头皮活性物质沉积的不含硫酸盐的组合物
WO2021173203A1 (en) 2020-02-27 2021-09-02 The Procter & Gamble Company Anti-dandruff compositions with sulfur having enhanced efficacy and aesthetics
CN112245416A (zh) * 2020-11-17 2021-01-22 广西馨海药业科技有限公司 Pinnatifolone A在制备具有镇静、催眠作用药物中的应用及药物组合物
WO2022109094A1 (en) 2020-11-23 2022-05-27 The Procter & Gamble Company Personal care compositions free of sulfated surfactants
JP7768985B2 (ja) 2020-12-04 2025-11-12 ザ プロクター アンド ギャンブル カンパニー 悪臭低減物質を含むヘアケア組成物
KR102383733B1 (ko) * 2021-02-18 2022-04-11 고려대학교 산학협력단 세스퀴테르펜 유도체를 유효성분으로 포함하는 근감소증 예방 또는 치료용 약학적 조성물
US11771635B2 (en) 2021-05-14 2023-10-03 The Procter & Gamble Company Shampoo composition
US11986543B2 (en) 2021-06-01 2024-05-21 The Procter & Gamble Company Rinse-off compositions with a surfactant system that is substantially free of sulfate-based surfactants
MX2024005346A (es) 2021-12-09 2024-05-20 Procter & Gamble Composicion de limpieza personal libre de sulfato que comprende conservacion efectiva.
CN115282131B (zh) * 2022-07-26 2023-10-10 东莞广州中医药大学研究院 一种治疗非酒精性脂肪肝的药物组合物及其应用
CN119345323B (zh) * 2024-11-01 2025-08-26 山东艾美科生物技术有限公司 角豆提取物在改善糖代谢女性多囊卵巢综合征药物中的应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US702722A (en) 1901-11-21 1902-06-17 William Gorman Heating-furnace.
JP3113759B2 (ja) * 1993-05-17 2000-12-04 花王株式会社 セスキテルペン誘導体
AU8352098A (en) * 1997-07-24 1999-03-01 Zografos-Dietetic Products S.A.C.I. Products from cypress and all relative coniferous trees and their pharmaceuticaluses
US6379674B1 (en) 1997-08-12 2002-04-30 Georgetown University Use of herpes vectors for tumor therapy
FR2773079B1 (fr) 1997-12-30 2002-05-17 Itzik Harosh Cible de traitement de l'atherosclerose, de l'obesite et du diabete de type ii
MXPA02000927A (es) 1999-07-28 2003-07-14 Johnson & Johnson Amina y derivados de amida como ligandos para el receptor del neuropeptido y y5 utiles en el tratamiento de obesidad y otros trastornos.
JP2001247461A (ja) * 2000-03-03 2001-09-11 Zenyaku Kogyo Kk 糖尿病予防・改善剤
US6680387B2 (en) 2000-04-24 2004-01-20 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
US6987131B1 (en) 2000-06-26 2006-01-17 Burzynski Stanislaw R Phenylacetic acid compositions for treating or preventing hypercholesterolemia
US7135575B2 (en) * 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
US20050271755A1 (en) * 2004-05-12 2005-12-08 Ilya Raskin Phytomedicinal compositions for the control of lipid accumulation and metabolism in mammals
JP2006241287A (ja) * 2005-03-02 2006-09-14 Suntory Ltd 脂質代謝改善作用を有する組成物
KR100711028B1 (ko) * 2005-07-13 2007-04-24 한국생명공학연구원 향나무 추출물 또는 세드롤을 포함하는 비만 및 제2형당뇨병 예방 및 치료용 조성물
WO2007066305A1 (en) * 2005-12-09 2007-06-14 Zelpy 2549 (Pty) Limited Compositions comprising sesquiterpene compounds for use in the prophylaxis or treatment of pain

Also Published As

Publication number Publication date
US20120129924A1 (en) 2012-05-24
EP2331089A4 (en) 2011-12-21
CN102143741A (zh) 2011-08-03
BRPI0823082B1 (pt) 2019-02-26
WO2010030054A3 (en) 2010-07-15
WO2010030054A2 (en) 2010-03-18
MX2011001594A (es) 2011-06-27
JP5435375B2 (ja) 2014-03-05
EP2331089A2 (en) 2011-06-15
KR100905419B1 (ko) 2009-07-02
BRPI0823082B8 (pt) 2021-05-25
EP2331089B1 (en) 2015-12-16
JP2012502094A (ja) 2012-01-26
ES2560533T3 (es) 2016-02-19
CN102143741B (zh) 2013-09-11
US8481592B2 (en) 2013-07-09

Similar Documents

Publication Publication Date Title
BRPI0823082A2 (pt) Uso derivados de sesquiterpeno
BRPI0821668A2 (pt) Uso
BRPI0813707A2 (pt) Derivados de pirimidinil-piridazinona
BRPI0820112A2 (pt) Derivados de isoxazol-piridina
BRPI0809992A2 (pt) Derivados de pirrolopirimidina
BRPI0820113A2 (pt) Derivados de isoxazolo-piridazina
BRPI0812155A2 (pt) derivados de espiroindolinona
SMT201500218B (it) Composti aril-fenil-solfonammido-cicloalchile e loro uso
BRPI0817935A2 (pt) Derivados de biarila
DK2308877T3 (da) Imidazopyridin-2-on-derivater
BRPI0915064A2 (pt) derivados de qunoxalinadiona
BRPI0911563A2 (pt) uso de antagonista da progesterona
BRPI0814236A2 (pt) Derivados de quinazolinamida
BRPI0813836A2 (pt) Derivados pirazólicos
BRPI0915086A2 (pt) detecção do uso de canabis
BRPI0812518A2 (pt) Derivados de indazolamida
BRPI0913832A2 (pt) derivados de pirrolopiridinilpirimidin-2-ilamina
BRPI0820649A2 (pt) Derivados de isoxazalo-pirazina
BRPI0914301A2 (pt) derivados de pirimidin-4-ona substituída
DK2152370T3 (da) Aryletherpyridazinonderivater
DK2275414T3 (da) Cyclopentylacrylamidderivat
DK2195293T3 (da) Cyclopropylamidderivater
ITMI20080003A1 (it) Composizioni per uso oftalmico
BRPI0913234A2 (pt) derivados de tiazolilpiperidina
BRPI0917446A2 (pt) derivados de acilaminobenzamida.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 26/02/2019, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 20/10/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 16A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2797 DE 13-08-2024 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.